Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics

被引:5
|
作者
Fukunishi, Yoshifumi [1 ,2 ]
Mashimo, Tadaaki [2 ,3 ]
Misoo, Kiyotaka [2 ,3 ]
Wakabayashi, Yoshinori [4 ]
Miyaki, Toshiaki [5 ]
Ohta, Seiji [6 ]
Nakamura, Mayu [6 ]
Ikeda, Kazuyoshi [6 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[2] Technol Res Assoc Next Generat Nat Prod Chem, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[3] IMSBIO Co Ltd, Toshima Ku, Owl Tower,4-21-1 Higashi Ikebukuro, Tokyo 1700013, Japan
[4] BY HEX LLP, Suginami Ku, 1-19-14 Shimizu, Tokyo 1670033, Japan
[5] DiscoveResource Inc, Minato Ku, 2-4-15 Minami Aoyama, Tokyo 1070062, Japan
[6] LEVEL FIVE Co Ltd, Minato Ku, 21F,Shiodome Shibarikyu Bldg 1-2-3, Tokyo 1050022, Japan
关键词
Computer-aided drug design; Synthetic accessibility; Cloud computing; GPU computing; Virtual screening; Molecular dynamics simulation; MOLECULAR-DYNAMICS SIMULATIONS; CHEMISTRY; COMPLEXITY; CLOUD; ZINC;
D O I
10.2174/1381612822666160414142547
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design.
引用
收藏
页码:3555 / 3568
页数:14
相关论文
共 50 条
  • [31] Active search for computer-aided drug design
    Hirst, Jonathan
    Oatley, Steven
    Oglic, Dino
    Gaertner, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [32] Computer-aided drug design: Successes and opportunities
    Holloway, M.
    Reynolds, Charles
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [33] Recent advances in computer-aided drug design
    Song, Chun Meng
    Lim, Shen Jean
    Tong, Joo Chuan
    BRIEFINGS IN BIOINFORMATICS, 2009, 10 (05) : 579 - 591
  • [34] Computer-aided drug design at Boehringer Ingelheim
    Muegge, Ingo
    Bergner, Andreas
    Kriegl, Jan M.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2017, 31 (03) : 275 - 285
  • [35] SPECIAL ISSUE - COMPUTER-AIDED DRUG DESIGN
    RICHARDS, WG
    JOURNAL OF MOLECULAR GRAPHICS, 1986, 4 (01): : 2 - 2
  • [36] NEW METHODS IN COMPUTER-AIDED DRUG DESIGN
    SHERIDAN, RP
    VENKATARAGHAVAN, R
    ACCOUNTS OF CHEMICAL RESEARCH, 1987, 20 (09) : 322 - 329
  • [37] Active search for computer-aided drug design
    Hirst, Jonathan
    Oatley, Steven
    Oglic, Dino
    Gaertner, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [38] Active Search for Computer-aided Drug Design
    Oglic, Dino
    Oatley, Steven A.
    Macdonald, Simon J. F.
    Mcinally, Thomas
    Garnett, Roman
    Hirst, Jonathan D.
    Gartner, Thomas
    MOLECULAR INFORMATICS, 2018, 37 (1-2)
  • [39] Computer-aided drug design: Looking forward
    Peishoff, Catherine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [40] Computer-aided drug design at Boehringer Ingelheim
    Ingo Muegge
    Andreas Bergner
    Jan M. Kriegl
    Journal of Computer-Aided Molecular Design, 2017, 31 : 275 - 285